Scientific Library
Three new pseudoviruses for SARS-CoV-2 studies
To better understand the mechanism of SARS-CoV-2 cell entry, BPS Bioscience have developed 3 new pseudotyped lentiviruses, allowing you to study the interaction between the coronavirus Spike protein and
Human and Viral proteases as targets for SARS-CoV-2 treatment?
Researchers have shown that proteases are actively used by SARS-CoV-2 for it's entry and replication into human cells. To support research on this topic, tebu-bio provides a full range of screening kits
Reprogramming stem cells: a new innovative technology for the development of consistent and functional human cells
To overcome current cell model limitations, bit.bio have developed a new, innovative technology to reprogram human stem cells with precise control of transcription factor expression through iPSC engineering.
Consistent, scalable human iPSC-derived glutamatergic neurons and skeletal myocytes
As detailed in a separate post, bit.bio have developed a novel cellular reprogramming technology, opti-ox™1 (optimized inducible overexpression), that can generate functional cells with high consistency
Siglecs as the new immunecheckpoint target
Due to their involvement as checkpoints in immune cell responses, Sialic-acid-binding ImmunoGlobulin-like Lectins (Siglecs) have gained more and more interest as therapeutic targets in Immuno-Oncology
ADCC and SARS-CoV-2 - how is their destiny linked?
Since its emergence in 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has rapidly spread to become the major health issue of the past two years. But it's also a research field of interest
New cancer treatment may reawaken the immune system
Cancer is a disease caused by abnormal cell growth. The cells’ genetic material is corrupted and the metabolic processes do not interact well with them anymore. They grow unchecked, mostly in the form
Unlocking the Power of Immuno-Oncology: Cutting-Edge Tools for Cancer Research
Access an exciting on-demand webinar where we dive into the latest therapeutic strategies leveraging the immune system to combat cancer, with a focus on
Assessing Cellular PARylation: Convenient ELISA-Based Methods
Discover how ELISA-based methods enable precise PARylation assessment in intact cells. Learn about the role of PARP and PARG inhibitors in drug discovery and cancer research.
Explore commercial kits for
LIVE-Stepâ„¢ Cell Assay System: A Next-Generation Solution for Measuring Cell Viability
Discover the LIVE-Stepâ„¢ Cell Assay System: a fast, sensitive, and cost-effective solution for measuring cell viability in drug screening, cancer research, and toxicity studies.
Learn how this ATP-based
Bispecific Antibodies: A Revolution in Cancer Treatment
In this blog, we will delve into how BITE antibodies, are transforming cancer treatment strategies, with a special focus on the tools developed by our partner, BPS Biosciences, to help you develop and
Gamma Delta T Cells : A promising Avenue for Novel Cancer Immunotherapies
In this blog, we delve into the potential of Gamma Delta (γδ) T cells in the development of new cancer treatment, and how thanks to the tools developed by our partner BPS Bioscience we can support you